<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04367272</url>
  </required_header>
  <id_info>
    <org_study_id>27.04.2020-02</org_study_id>
    <nct_id>NCT04367272</nct_id>
  </id_info>
  <brief_title>Is Second Knee at Risk During Simultaneous Bilateral Total Knee Arthroplasty.</brief_title>
  <official_title>Is Second Knee at Risk During Simultaneous Bilateral Total Knee Arthroplasty.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bezmialem Vakif University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bezmialem Vakif University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effects of single-team simultaneous bilateral total knee arthroplasty on peri- and
      postoperative complications are clear. The investigators hypothesized that second knee at
      risk during single-team simultaneous bilateral total knee arthroplasty and have more early
      postoperative complication rates than the first knee. Therefore, this prospective study
      compared minor and major local complications for 90 days postoperatively between the first
      and second during knee single-team simultaneous bilateral total knee arthroplasty.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators would like to compare operation related technical complications and
      periprosthetic joint infection rate between the first and second knee.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 15, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Local complications</measure>
    <time_frame>90 days</time_frame>
    <description>Local operation related complications rate</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">163</enrollment>
  <condition>Osteoarthritis, Knee</condition>
  <condition>Infection</condition>
  <condition>Periprosthetic Fracture Around Prosthetic Joint Implant</condition>
  <arm_group>
    <arm_group_label>First Knee</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The first knee is the knee where the surgery will begin to be applied.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Second Knee</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The second knee is the knee where the surgeon will apply secondly.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>First Arthroplasty</intervention_name>
    <description>First Knee</description>
    <arm_group_label>First Knee</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Second Arthroplasty</intervention_name>
    <description>Second Knee</description>
    <arm_group_label>Second Knee</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary bilateral knee osteoarthritis with refractory to conservative treatment

          -  Patients who accept participation in the research and the randomization

        Exclusion Criteria:

          -  no history of malignancy

          -  less than 75 years old

          -  severe cardiac insufficiency and morbid obesity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Orkhan Aliyev, MD</last_name>
    <phone>+905059917419</phone>
    <email>orkhanaliyev@outlook.com.tr</email>
  </overall_contact>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 25, 2020</study_first_submitted>
  <study_first_submitted_qc>April 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 29, 2020</study_first_posted>
  <last_update_submitted>April 29, 2020</last_update_submitted>
  <last_update_submitted_qc>April 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bezmialem Vakif University</investigator_affiliation>
    <investigator_full_name>Orkhan Aliyev</investigator_full_name>
    <investigator_title>Residents Doctor in Orthopedics Department, Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis, Knee</mesh_term>
    <mesh_term>Periprosthetic Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

